Hamilton James C 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Aug 15, 2025
Insider Transaction Report
Form 4
Hamilton James C
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-08-13$20.00/sh−611$12,220→ 271,511 total - Sale
Common Stock
2025-08-15$20.00/sh−9,389$187,780→ 262,122 total
Footnotes (2)
- [F1]Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.